Peter Dias

Universidade Federal do Rio de Janeiro — Brazil

Medicine · Health Sciences

18h-index1.6kcitations28works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sarcoma Diagnosis and Treatment(14), Tumors and Oncological Cases(4), Muscle Physiology and Disorders(3), Cancer-related molecular mechanisms research(3), Cardiac tumors and thrombi(3)

Publications28 total

Differential influence of gp63-like molecules in three distinct Leptomonas species on the adhesion to insect cells
Parasitology Research·2008· 17 cited
Strong Immunostaining for Myogenin in Rhabdomyosarcoma Is Significantly Associated with Tumors of the Alveolar Subclass
American Journal Of Pathology·2000· 189 citedOpen Access
Untitled
Applied Immunohistochemistry·1999
Comparison of MyoD1 Immunostaining of Pediatric Tumors Using Frozen or Paraffin-Embedded Sections
Applied immunohistochemistry & molecular morphology·1999· 2 cited
Activated Astrocytes Display Increased 5-HT2a Receptor Expression in Pathological States
Experimental Neurology·1999· 42 cited
Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
PubMed·1998· 21 cited
Development and Characterization of Monoclonal Antibodies Specific to the Serotonin 5-HT<sub>2A</sub> Receptor
Journal of Histochemistry & Cytochemistry·1998· 69 citedOpen Access
Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas.
PubMed·1998· 46 cited
Live food production using batch culture and chemostat systems in Kuwait
Hydrobiologia·1997· 13 cited
Monoclonal Antibodies Specific to the Acute Lymphoblastic Leukemia t(1; 19)-Associated E2A/pbx1 Chimeric Protein: Characterization and Diagnostic Utility
Blood·1997· 35 citedOpen Access
Alpha 2a-interferon-induced differentiation of human alveolar rhabdomyosarcoma cells: correlation with down-regulation of the insulin-like growth factor type I receptor.
PubMed·1996· 31 cited
Immunohistochemistry of MyoD1 in Adult Pleomorphic Soft Tissue Sarcomas
The American Journal of Surgical Pathology·1995· 51 cited
Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma.
Journal of Clinical Investigation·1994· 168 citedOpen Access
Immunohistochemical analysis of the distribution of MyoD1 in muscle biopsies of primary myopathies and neurogenic atrophy
Acta Neuropathologica·1994· 12 cited
Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.
Molecular Pharmacology·1994· 16 cited
Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation.
PubMed·1994· 66 citedOpen Access
Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor.
PubMed·1994· 135 cited
The molecular basis of skeletal muscle differentiation.
PubMed·1994· 89 cited
Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility.
PubMed·1992· 108 cited
Prognostic relevance of DNA ploidy in rhabdomyosarcomas and other sarcomas of childhood.
PubMed·1992· 5 cited
page 1 of 2Next →

Frequent Co-authors

David M. Parham(11), Peter J. Houghton(10), David N. Shapiro(5), Peter J. Houghton(4), H. B. Marsden(4), Sujay Singh(3), Patricia Kumar(3), H. Rao Gattamaneni(3), S. Kumar(3), Bin Chen(2), Chun Wu(2), Glen S. Germain(2), Juan Rosaí(2), Jim Heighway(2), Liangru Shi(2), S Kumar(2), Perkins Mukunyadzi(2), Hb Marsden(2), Brad Dilday(1), Hal E. Palmer(1)